Cargando…

Targeted Therapies and Druggable Genetic Anomalies in Acute Myeloid Leukemia: From Diagnostic Tools to Therapeutic Interventions

Detalles Bibliográficos
Autores principales:	Lanza, Francesco, Bazarbachi, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466687/ https://www.ncbi.nlm.nih.gov/pubmed/34572925 http://dx.doi.org/10.3390/cancers13184698

Ejemplares similares

NF-κB: A Druggable Target in Acute Myeloid Leukemia
por: Di Francesco, Barbara, et al.
Publicado: (2022)

Functional Dependency Analysis Identifies Potential Druggable Targets in Acute Myeloid Leukemia
por: Zhou, Yujia, et al.
Publicado: (2020)

Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia
por: Muselli, Fabien, et al.
Publicado: (2019)

Discovery of druggable cancer-specific pathways with application in acute myeloid leukemia
por: Trac, Quang Thinh, et al.
Publicado: (2022)

Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia
por: Rocca, Stefania, et al.
Publicado: (2018)

Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin
por: Gottardi, Michele, et al.
Publicado: (2021)

The Tumor Microenvironment: A Druggable Target for Metastatic Disease?
por: EBioMedicine
Publicado: (2018)

Druggable genetic targets in endometrial cancer
por: Lehrer, Steven, et al.
Publicado: (2022)

Targeting PR1 in myeloid leukemia
por: Alatrash, Gheath, et al.
Publicado: (2017)

FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis
por: Kim, Jieun, et al.
Publicado: (2023)

Fusion genes in acute myeloid leukemia: do acute myeloid leukemia diagnostics need to fuse with RNA-sequencing?
por: Thol, Felicitas
Publicado: (2022)

Druggable targets and therapeutic development for COVID-19
por: Duan, Xiaohua, et al.
Publicado: (2022)

Druggable Drivers of Lung Cancer
por: Fawdar, Shameem, et al.
Publicado: (2013)

The changing face of acute myeloid leukemia therapeutics in the elderly population
por: Daver, Naval, et al.
Publicado: (2015)

Unveiling the druggable RNA targets and small molecule therapeutics
por: Sztuba-Solinska, Joanna, et al.
Publicado: (2019)

Aurora Kinases as Druggable Targets in Pediatric Leukemia: Heterogeneity in Target Modulation Activities and Cytotoxicity by Diverse Novel Therapeutic Agents
por: Jayanthan, Aarthi, et al.
Publicado: (2014)

Identification of New Druggable Antiviral Targets by Chemical Genetics
por: Kao, Richard Y., et al.
Publicado: (2011)

VAV2: a novel prognostic marker and a druggable target for adrenocortical carcinoma
por: Ruggiero, Carmen, et al.
Publicado: (2017)

Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets
por: Souza, Rhonda F.
Publicado: (2018)

Pharmacologic Strategies for Post-Transplant Maintenance in Acute Myeloid Leukemia: It Is Time to Consider!
por: Abou Dalle, Iman, et al.
Publicado: (2022)

Drug Normalization for Cancer Therapeutic and Druggable Genome Target Discovery
por: Jiang, Guoqian, et al.
Publicado: (2015)

Druggable Molecular Pathways in Chronic Lymphocytic Leukemia
por: Almasri, Mohammad, et al.
Publicado: (2022)

Basigin is a druggable target for host-oriented antimalarial interventions
por: Zenonos, Zenon A., et al.
Publicado: (2015)

Monobodies as tool biologics for accelerating target validation and druggable site discovery
por: Akkapeddi, Padma, et al.
Publicado: (2021)

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023)

Novel Biomarkers and Druggable Targets in Advanced Melanoma
por: Ferrucci, Pier Francesco, et al.
Publicado: (2021)

Genetics of congenital anomalies of the hand
por: Kyriazis, Zisis, et al.
Publicado: (2022)

Therapeutic Targets in Chronic Lymphocytic Leukemia
por: Laurenti, Luca, et al.
Publicado: (2020)

New Diagnostic and Therapeutic Tools for Thyroid Cancer
por: Fröhlich, Eleonore, et al.
Publicado: (2013)

DRUGGABLE MM THERAPEUTICS: PATHOGENETIC PATHWAYS
por: Ocio, Enrique M
Publicado: (2022)

ARQ531: the therapy that targets multiple pathways in acute myeloid leukemia
por: Hellmich, Charlotte, et al.
Publicado: (2020)

Reductive carboxylation of glutamine as a potential target in acute myeloid leukemia
por: Roma, Alessia, et al.
Publicado: (2023)

The Druggable Pocketome of Corynebacterium diphtheriae: A New Approach for in silico Putative Druggable Targets
por: Hassan, Syed S., et al.
Publicado: (2018)

Sortilin‐related receptor is a druggable therapeutic target in breast cancer
por: Al‐Akhrass, Hussein, et al.
Publicado: (2021)

A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
por: Tzelepis, Konstantinos, et al.
Publicado: (2016)

Therapeutic Target Discovery Using High-Throughput Genetic Screens in Acute Myeloid Leukemia
por: Liu, Qiao, et al.
Publicado: (2020)

Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML)
por: Gentil, Melanie, et al.
Publicado: (2018)

Myeloid Sarcoma Mimicking Dental Abscess in a Patient with Chronic Myeloid Leukemia: Diagnostic and Therapeutic Dilemma
por: Ali, Elrazi A., et al.
Publicado: (2022)

An integrated structural proteomics approach along the druggable genome of Corynebacterium pseudotuberculosis species for putative druggable targets
por: Radusky, Leandro G, et al.
Publicado: (2015)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_93775oair3vtc7fnuentv9n4uf